Known as "the silent killer" due to its lack of symptoms and reliable screening tests, ovarian cancer remains one of the ...

Several drug classes, including immunotherapy, antibody-drug conjugates and PARP inhibitors have helped improve outcomes for gynecologic cancers. Over the past 10 years, PARP inhibitors, immunotherapy ...

Analysis of data from over 1.2 million US patients with gynecologic cancers between 2004 and 2020 revealed a significant shift towards surgical de-escalation, with increased use of minimally invasive ...

Friday marks the end of September and with it the end of Gynecologic Cancer Awareness Month. But advocates hope awareness of the diseases won't go away. Cancers that make up the group may be less ...

Please provide your email address to receive an email when new articles are posted on . Many premenopausal women do not receive estrogen therapy after treatment for gynecologic cancer despite research ...

GREENSBORO, N.C. — Gynecologic cancers are often referred to as “silent” with subtle symptoms. It’s important to know the risk factors, how to recognize possible symptoms and when to contact a ...

The annual rate of radical hysterectomies performed by gynecologic oncologists in the US declines significantly despite a doubling of the workforce.

After being diagnosed with a type of gynecologic cancer, it is essential for patients to understand the molecular makeup of their disease. Gynecologic cancer is not a singular disease, but rather a ...

ChatGPT can accurately answer common questions pertaining to genetic testing and counseling for gynecologic cancers but stumbles when asked to provide the appropriate treatment option, according to a ...

In 2024, the American Cancer Society estimates that uterine cancer will surpass ovarian cancer in total estimated number of deaths in the United States. That’s partly due to the progress made in ...

Luveltamab tazevibulin, a novel ADC, showed encouraging responses in platinum-resistant ovarian cancer, with a 32% ORR and a ...